2-Bromo-4,5-methylenedioxyamphetamine
 | |
| Names | |
|---|---|
| IUPAC name
2-(6-Bromobenzo[1,3]dioxol-5-yl)-1-methylethylamine | |
| Other names
2-Bromo-4,5-methylenedioxyamphetamine 2-(2-Bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine | |
| Identifiers | |
151920-03-5  | |
| 3D model (Jmol) | Interactive image Interactive image |
| ChemSpider | 23552998  |
| |
| |
| Properties | |
| C11H17NO2Br | |
| Molar mass | 258.11 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| verify (what is ?) | |
| Infobox references | |
2-Bromo-4,5-methylenedioxyamphetamine (6-Bromo-MDA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 350 mg, and the duration unknown. It produces stimulant effects but with no psychedelic or empathogenic action.[1] Very little data exists about its pharmacological properties, metabolism, and toxicity.
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
See also
External links
This article is issued from Wikipedia - version of the 10/15/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.